1. Home
  2. Browse
  3. Cardiology
  4. Dyslipidemia

Dyslipidemia

211 - 225 of 299 Results
Sort Results:
Commentary: Intensive Blood Pressure and Lipid Control for Patients with Diabetes: More from ACCORD April 2010
Commentary: Increased Risk of Muscle Injury with High-Dose Zocor (Simvastatin) April 2010
Article: Stronger warnings about an increased risk of myopathy will limit doses of simvastatin (Zocor, etc) April 2010
Article: whether intensive treatment of blood pressure or lipids is beneficial for type 2 diabetes patients April 2010
Article: Crestor to reduce cardiovascular risk in some patients WITHOUT high cholesterol March 2010
Article: The Zetia controversy and New Year's resolutions will spark new emphasis on treating lipids January 2010
Commentary: Ezetimibe vs. Niacin for Atherosclerosis: The ARBITER 6-HALTS Study January 2010
Other: Niacin Titration Schedule January 2010
Article: debate about whether to use ezetimibe (Vytorin, Zetia) for dyslipidemia December 2009
Article: More questions about resolving statin myopathy will come up October 2009
Commentary: Generic Drug Approval Process: An Update October 2009
Guideline: Use and Safety of Statins (ACC/AHA/NHLBI, 2002) October 2009
Article: avoid time-consuming hassles when a prescribed drug turns out not to be on formulary August 2009
Chart: Proton Pump Inhibitor Dose Comparison August 2009
Chart: Histamine H2 Blocker Oral Dose Comparison August 2009